Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction

Kidney International

Volumn 66, Issue 2, 2004, Pages 597-604

  Inazaki, Kumi ^b   Kanamaru, Yutaka ^b   Kojima, Yuko ^b   Sueyoshi, Noriyoshi ^b   Okumura, Ko ^b   Kaneko, Kazunari ^b   Yamashiro, Yuichiro ^b   Ogawa, Hideoki ^b   Nakao, Atsuhito ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NONE

Author keywords

Apoptosis; Fibrosis; Inflammation; Smad; UUO

Indexed keywords

ANILINE; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; COLOR; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; MYOFIBROBLAST; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD3 DEFICIENCY; STAINING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; URETER OBSTRUCTION; WILD TYPE;

EID: 3242797424     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00779.x     Document Type: Article

References (34)

1. KLAHR S, SCHREINER G, ICHICAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
2. EDDY AA: Molecular insight into renal interstitial fibrosis. J Am Soc Nephrol 7:2945-2508, 1996
3. KLAHR S, MORRISSEY J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283:F861-F875, 2002
4. WALTON G, BUTTYAN R, GARCIA ME, et al: Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148:510-514, 1992
5. DIAMOND JR, KEES FD, DING G, et al: Macrophages, monocyte chemoattractant peptide-1, and TGF-β1 in experimental hydronephrosis. Am J Physiol Renal Fluid Electrolyte Physiol 266:F874-F881, 1993
6. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
7. SUTARIA PM, OHEBSHALOM M, MCCAFFREY TA, et al: Transforming growth factor-β receptor type I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 62:1965-1972, 1998
8. MIYAJIMA A, CHEN J, LAWRENCE C, et al: Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301-2313, 2000
9. ISAKA Y, TSUJIE M, ANDO Y, et al: Transforming growth factor-β1 antisense oligonucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892, 2000
10. FUKUDA K, YOSHITOMI K, YANAGIDA T, et al: Quantification of TGF-β1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281:F513-F521, 2001
11. BORDER W, NOBLE N: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
12. SCHNAPER HW, HAYASHIDA T, HUBCHAK SC, PONCELET AC: TGF-β signal transduction and mesangial cell fibrosis. Am J Physiol Renal Physiol 284:F243-F252, 2003
13. TOMASEK JJ, GABBIANI G, HINZ B, et al: Myofibroblasts and mechanoregulaton of connective tissue remodeling. Nature Rev Mol Cell Biol 3:349-363, 2002
14. HELDIN CH, MIYAZONO K, TEN DIJKE P: TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
15. MASSAGUE J: How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169-178, 2000
16. ATTISANO L, WARANA JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 12:235-243, 2000
17. YANG X, LETTERIO JJ, LECHLEIDER RJ, et al: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18:1280-1291, 1999
18. DATTO MB, FREDERICK JP, PAN L, et al: Targeted disruption of Smad3 reveals an essential role in transforming growth factor-β-mediated signal transduction. Mol Cell Biol 19:2495-2504, 1999
19. ZHU Y, RICHARDSON JA, PARADA LF, et al: Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714, 1998
20. NOMURA M, LI E: Smad2 role in mesoderm formation, left-right patterning, and craniofacial development. Nature 393:786-790, 1998
21. WALDRIP WR, BIKOFF EK, HOODLESS PA, et al: Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808, 1998
22. WEINSTEIN M, YANG X, Li C, et al: Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc Natl Acad Sci USA 95:9378-9383, 1998
23. FUJIMOTO M, MAEZAWA Y, YOKOTE K, et al: Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 305:1002-1007, 2003
24. ODA T, JUNG YO, KIM HS, et al: PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 30:587-596, 2001
25. VERRECCHIA F, MAUVIL A: Transforming growth factor-β signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211-215, 2002
26. HU B, WU Z, PHAM SH: Smad3 mediates transforming growth factor-β induced α-smooth muscle actin expression. Am J Resp Cell Mol Biol 29:397-404, 2003
27. ASHCROFT GS, YANG X, GLICK AB, et al: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260-266, 1999
28. YANG YA, TANG B, ROBINSON G, et al: Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-β. Cell Growth Differ 13:123-130, 2002
29. EVANS RA, TIAN YC, STEADMAN R, PHILIPS AO: TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 282:90-100, 2003
30. LETTERIO JJ, ROBERTS AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 16:137-154, 1998
31. DAI C, YANG J, LIU Y: Transforming growth factor-β1 potentiates renal tubular epithelial death by a mechanism independent of Smad signaling. J Biol Chem 278:12537-12545, 2003
32. MIZUNO S, MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59:1304-1314, 2001
33. LAN HY, MU W, TOMITA N, et al: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14:1535-1548, 2003
34. SATO M, MURAGAKI Y, SAIKA S, et al: Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486-1494, 2003